VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
KRMD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
KRMDKORU Medical Systems, Inc.
$3.27$150M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksKRMDQuarterly Financials

KORU Medical Systems, Inc. (KRMD) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

KORU Medical Systems, Inc. (KRMD) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

KRMD Income Statement

Quarterly statement

KRMD Income Statement

KORU Medical Systems, Inc. (KRMD) annual income statement — 27-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue12.05M11.76M10.9M10.4M10.19M9.64M8.84M8.18M8.43M8.2M7.19M7M6.94M7.39M7.34M7.76M6.55M6.24M6.49M6.04M
Revenue Growth %18.15%22.1%23.27%27.17%20.93%17.53%23%16.8%21.54%10.89%-2.16%-9.76%5.95%18.39%13.16%28.47%18.42%14.98%59.97%-0.65%
Cost of Goods Sold4.2M4.73M4.08M4.14M3.72M3.59M3.28M2.99M2.95M3.09M2.85M2.66M3.05M3.25M3.27M3.44M3.2M2.62M2.66M2.54M
COGS % of Revenue34.86%40.21%37.43%39.78%36.48%37.25%37.06%36.6%35%37.75%39.73%38%43.94%43.9%44.47%44.3%48.89%41.99%40.96%42.13%
Gross Profit7.85M7.03M6.82M6.26M6.48M6.05M5.56M5.19M5.48M5.1M4.33M4.34M3.89M4.15M4.08M4.32M3.35M3.62M3.83M3.5M
Gross Margin %65.14%59.79%62.57%60.22%63.52%62.75%62.94%63.4%65%62.25%60.27%62%56.06%56.1%55.53%55.7%51.11%58.01%59.04%57.87%
Gross Profit Growth %21.16%16.33%22.55%20.8%18.18%18.48%28.44%19.43%40.94%23.06%6.2%0.46%16.2%14.49%6.43%23.65%4.24%12.08%66.8%-11.29%
Operating Expenses7.22M7.9M7.36M7.13M6.79M7.29M7.15M6.89M6.67M7.06M6.53M6.13M7.11M7.2M6.59M5.85M6.96M6.75M5.94M4.82M
OpEx % of Revenue59.93%67.14%67.59%68.57%66.59%75.67%80.92%84.22%79.14%86.18%90.85%87.58%102.55%97.45%89.72%75.41%106.31%108.08%91.59%79.76%
Selling, General & Admin5.94M6.58M6.04M5.99M0005.13M000000000000
SG&A % of Revenue49.31%55.95%55.44%57.63%---62.69%------------
Research & Development1.07M1.32M1.14M933.11K1.19M1.11M1.11M1.53M1.13M1.48M1.29M1.29M1.6M1.56M1.64M862.15K1.3M1.15M949.93K800.02K
R&D % of Revenue8.88%11.19%10.51%8.97%11.72%11.57%12.61%18.75%13.45%18%17.92%18.47%23.02%21.17%22.36%11.11%19.91%18.39%14.64%13.24%
Other Operating Expenses210.03K0179.17K204.48K1000K1000K1000K227.78K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income626.99K-864.92K-547.1K-867.68K-312.65K-1.25M-1.59M-1.7M-1.19M-1.96M-2.2M-1.79M-3.22M-3.06M-2.51M-1.53M-3.61M-3.13M-2.11M-1.32M
Operating Margin %5.21%-7.35%-5.02%-8.34%-3.07%-12.92%-17.98%-20.82%-14.14%-23.93%-30.58%-25.57%-46.49%-41.35%-34.19%-19.71%-55.2%-50.07%-32.56%-21.89%
Operating Income Growth %300.54%30.53%65.58%49.06%73.77%36.52%27.67%4.9%63.03%35.84%12.5%-17.1%10.76%2.23%-18.85%-15.69%-161.65%-41.26%-81.48%-468.43%
EBITDA837.02K-667.39K-367.93K-663.2K-103.17K-1.03M-1.49M-1.48M-974.17K-1.73M-1.97M-1.58M-3.01M-2.84M-2.32M-1.37M-3.49M-3.02M-2M-1.21M
EBITDA Margin %6.95%-5.67%-3.38%-6.38%-1.01%-10.67%-16.9%-18.04%-11.56%-21.1%-27.4%-22.49%-43.42%-38.47%-31.64%-17.59%-53.27%-48.32%-30.81%-19.97%
EBITDA Growth %911.32%35.06%75.37%55.05%89.41%40.6%24.15%6.32%67.65%39.16%15.26%-15.37%13.65%5.75%-16.2%-13.19%-176.21%-43.83%-91.62%-354.2%
D&A (Non-Cash Add-back)210.03K197.53K179.17K204.48K209.49K217.36K95.87K227.79K217.86K231.37K228.34K216.01K212.92K213.12K187.66K164.34K125.88K109.25K113.31K115.93K
EBIT258.25K-807.08K-482.17K-778.12K-189.51K-1.17M-1.59M-1.58M-988.72K-1.94M-2.2M-1.79M-3.22M-3.06M-2.51M-1.53M-3.61M-3.13M-2.11M-1.32M
Net Interest Income59.87K81K66.7K74.57K78.95K73.18K80.46K113K214K37.19K169.23K135.43K131.17K125.5K101.01K42.48K3.57K-1.46K-3.8K-2.84K
Interest Income59.87K81K66.7K74.57K78.95K73.18K80.46K113K214K37.19K169.23K135.43K131.17K125.5K101.01K42.48K3.57K000
Interest Expense000000000000000001.46K3.8K2.84K
Other Income/Expense-368.74K57.84K64.93K89.56K123.14K78.77K31.28K122.48K203.32K25.41K176.65K122.51K128.69K68.54K100.03K32.42K-18.14K-8.6K668.96K-9.85K
Pretax Income258.25K-807.08K-482.17K-778.12K-189.51K-1.17M-1.56M-1.58M-988.72K-1.94M-2.02M-1.67M-3.1M-2.99M-2.41M-1.5M-3.63M-3.14M-1.44M-1.33M
Pretax Margin %2.14%-6.86%-4.43%-7.48%-1.86%-12.1%-17.63%-19.33%-11.73%-23.62%-28.12%-23.82%-44.64%-40.42%-32.83%-19.29%-55.47%-50.21%-22.25%-22.05%
Income Tax5.8K04.68K-15017.36K02.89K0005.45M-300.25K-600K-577.4K-434.66K-271.5K-710.26K-597.6K-375.84K-238.1K
Effective Tax Rate %2.25%0%-0.97%0.02%-9.16%0%-0.19%0%0%0%-269.44%17.99%19.38%19.32%18.03%18.14%19.56%19.06%26.02%17.88%
Net Income252.45K-807.08K-486.86K-777.97K-206.87K-1.17M-1.56M-1.58M-988.72K-1.94M-7.47M-1.37M-2.5M-2.41M-1.98M-1.23M-2.92M-2.54M-1.07M-1.09M
Net Margin %2.1%-6.86%-4.47%-7.48%-2.03%-12.1%-17.66%-19.33%-11.73%-23.62%-103.9%-19.54%-35.98%-32.61%-26.91%-15.79%-44.62%-40.64%-16.46%-18.11%
Net Income Growth %222.03%30.8%68.81%50.79%79.08%39.76%79.09%-15.53%60.39%19.7%-277.7%-11.64%14.56%4.99%-85.02%-12.05%-159.78%-98.84%-28%-538.96%
Net Income (Continuing)252.45K-807.08K-486.86K-777.97K-206.87K-1.17M-1.56M-1.58M-988.72K-1.94M-7.47M-1.37M-2.5M-2.41M-1.98M-1.23M-2.92M-2.54M-1.07M-1.09M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.01-0.02-0.01-0.02-0.00-0.03-0.03-0.03-0.02-0.04-0.16-0.03-0.05-0.05-0.04-0.03-0.07-0.06-0.02-0.02
EPS Growth %-42%69.21%51.3%79.17%29.25%78.69%-15%60.51%20%-266.97%-10.29%15.85%6.69%-81.67%-10.12%-156.92%-95.86%-25.65%-347%
EPS (Basic)0.01-0.02-0.01-0.02-0.00-0.03-0.03-0.03-0.02-0.04-0.16-0.03-0.05-0.05-0.04-0.03-0.07-0.06-0.02-0.02
Diluted Shares Outstanding49.51M46.36M46.19M46.24M46.19M45.98M45.91M45.85M45.81M45.71M45.67M45.64M45.61M45.49M45.37M45.04M44.92M44.67M44.57M44.32M
Basic Shares Outstanding46.08M46.36M46.19M46.24M46.19M45.98M45.91M45.85M45.81M45.71M45.67M45.64M45.61M45.49M45.37M45.04M44.92M44.67M44.57M44.32M
Dividend Payout Ratio--------------------